Krystal Biotech Ownership | Who Owns Krystal Biotech?
Krystal Biotech Ownership Summary
Krystal Biotech is owned by 97.50% institutional investors, 12.30% insiders. Fmr is the largest institutional shareholder, holding 15.14% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.54% of its assets in Krystal Biotech shares.
KRYS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Krystal Biotech | 97.50% | 12.30% | -9.80% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 4.28M | 15.14% | $786.67M |
Blackrock | 3.95M | 13.95% | $724.98M |
Vanguard group | 2.87M | 10.14% | $526.89M |
Avoro capital advisors | 2.43M | 8.60% | $446.80M |
State street | 1.33M | 4.71% | $244.77M |
Redmile group | 1.02M | 3.61% | $187.51M |
Frazier life sciences management | 988.46K | 3.49% | $181.52M |
Capital world investors | 878.16K | 3.10% | $161.26M |
Price t rowe associates inc /md/ | 600.14K | 2.12% | $110.21M |
Dimensional fund advisors lp | 580.45K | 2.05% | $106.59M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Redmile group | 1.02M | 11.34% | $187.51M |
Frazier life sciences management | 988.46K | 8.49% | $181.52M |
S squared | 85.22K | 6.91% | $15.65M |
Avoro capital advisors | 2.43M | 5.95% | $446.80M |
Decheng capital | 65.77K | 3.70% | $12.08M |
First turn management | 109.22K | 3.26% | $20.06M |
Soleus capital management | 126.00K | 2.04% | $23.14M |
Hood river capital management | 521.09K | 1.98% | $95.69M |
Evolutionary tree capital management | 8.94K | 1.69% | $1.64M |
Eam global investors | 28.84K | 1.19% | $5.30M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 3.95M | 0.02% | 2.14M |
Capital world investors | 878.16K | 0.03% | 781.01K |
Vanguard group | 2.87M | 0.01% | 436.36K |
State street | 1.33M | 0.01% | 388.33K |
Ubs asset management americas | 251.76K | 0.01% | 233.50K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Redmile group | 1.02M | 11.34% | -487.17K |
Ikarian capital | - | - | -375.00K |
Jennison associates | 520.39K | 0.06% | -150.34K |
Avoro capital advisors | 2.43M | 5.95% | -122.56K |
Lord, abbett | 392.24K | 0.23% | -99.99K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Eagle asset management | 76.26K | 0.07% | 76.26K | $13.90M |
Public sector pension investment board | 54.66K | 0.06% | 54.66K | $10.04M |
Segall bryant & hamill | 34.74K | 0.11% | 34.74K | $6.38M |
Alps advisors | 22.27K | 0.03% | 22.27K | $4.09M |
Thrivent financial for lutherans | 20.63K | 0.01% | 20.63K | $3.79M |
Sold Out
Holder | Change |
---|---|
Tfc financial management | -1.00 |
Cibc private wealth group | -4.00 |
Abich financial wealth management | -14.00 |
Itau unibanco | -14.00 |
Innealta capital | -14.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 297 | 16.47% | 27,997,874 | -1.68% | 97 | 0.98% | 156 | - | 92 | 31.43% |
Jun 30, 2024 | 253 | - | 28,459,261 | 12.90% | 100 | 1.17% | 155 | 18.32% | 69 | -19.77% |
Mar 31, 2024 | 253 | 24.63% | 25,206,890 | 3.33% | 92 | 1.23% | 131 | 31.00% | 86 | 26.47% |
Dec 31, 2023 | 203 | 2.01% | 24,393,819 | 2.62% | 86 | 1.09% | 100 | -7.41% | 68 | 23.64% |
Sep 30, 2023 | 199 | 1.02% | 23,770,031 | 3.14% | 89 | 1.11% | 108 | 1.89% | 55 | -9.84% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Biotechnology | 1.88M | 6.54% | - |
iShares Core S&P Small-Cap ETF | 1.61M | 5.60% | 1.42K |
Fidelity Growth Compy Commingled Pl S | 920.74K | 3.20% | 5.31K |
Fidelity Growth Compy Commingled Pl O | 915.43K | 3.19% | - |
Vanguard Total Stock Mkt Idx Inv | 820.96K | 2.85% | -3.76K |
American Funds SMALLCAP World A | 811.71K | 2.83% | - |
Fidelity Growth Company Fund | 679.02K | 2.36% | -1.44K |
Vanguard Small Cap Index | 648.50K | 2.25% | 1.25K |
iShares Russell 2000 ETF | 638.22K | 2.22% | -1.43K |
SPDR® S&P Biotech ETF | 505.52K | 1.76% | 5.61K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | $1.26M |
Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | $334.18K |
Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | $413.20K |
Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | $797.30K |
Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | $772.26K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 30 |
2024 Q2 | - | 35 |
2024 Q1 | - | 53 |
2023 Q4 | - | 16 |
2023 Q3 | - | 20 |
KRYS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools